Develops ready-to-use allogeneic stem cell therapies for veterinary medicine.
| Date | Round | Amount |
|---|---|---|
| Jul 2025 | Funding round Gallant raised $18M led by Digitalis Ventures to bring the first FDA-approved ready-to-use stem cell therapy to veterinary medicine. | $18M |
Tap an investor to see what else they have backed.
Data is community-curated and may be incomplete.